How much does Wegovy cost without insurance?

List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone).

Does insurance cover Zepbound?

Most commercial insurance plans cover Zepbound with prior authorization for adults with BMI ≥30 (or ≥27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law, so Medicare patients pay cash unless they qualify for Lilly Cares.

Is Ozempic the same as Wegovy?

Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different.

Can I still get compounded GLP-1 in 2026?

For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested.

How does Wegovy compare to Saxenda?

Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.

Home ProvidersTrimRX

Provider review

TrimRX

Item: TrimRX
Rating: 3.7
Author: Dr. Jane Novak

Cash-pay online GLP-1 program from $179/mo — compounded semaglutide + tirzepatide.

Medically reviewed by Dr. Jane Novak, MD, MPH 6 min read Fact checked Editorial integrity

Updated Jul 17, 2026

3.70/5 rating
From $179.00/mo
51 states
1 GLP-1

Medically reviewed by Dr. Jane Novak, MD, MPH on July 17, 2026

Rating breakdown

How this provider scored, per dimension

Editorial scores out of 5 — see our scoring rubric for the criteria behind each axis.

Overall: 3.7/5
Pricing: 4.3/5
Patient experience: 3.6/5
Delivery speed: 3.7/5
Customer support: 3.4/5
Billing clarity: 3.8/5

TrimRX provider review — TrimRX is a compounded GLP-1 provider operating in 51 U.S. states.Photo: Unsplash

From

$179/mo

Medications

1

States

51

Rating

3.7/5

Visit TrimRX Compare alternatives

We earn a commission if you sign up through this link. Editorial ranking is independent.

What we liked

Public entry pricing at $179/mo is competitive with Henry Meds ($297+) and Mochi ($269+) for compounded semaglutide
Nationwide 51-state footprint — same reach as the other cash-only compounded competitors
No membership fee gating consult or prescription

What gave us pause

Compounded-only pathway; brand-name Wegovy/Zepbound access is not the product
Reader complaint volume and specifics are still limited in our corpus — editorial rating is conservative pending real review data
FDA compounding-shortage exception ended Oct 2024 for semaglutide — check every provider (including TrimRX) for their 503A patient-specific compliance story

Reader reviews

Verified user experiences. Reviews are moderated before publishing — we strip personal info and reject spam.

Ready to try TrimRX?

From $179.00/mo. Commission-funded, editorially independent.

Get started with TrimRX

How to get started with TrimRX Start a TrimRX consultation

Common questions readers ask

How much does Wegovy cost without insurance?: List price runs ~$1,350/mo at retail. NovoCare Pharmacy cash-pay direct from Novo Nordisk is $499/mo for all dose strengths. The Wegovy Savings Offer caps copay at $0-$225/mo for commercially insured patients depending on coverage status (not a flat $225 for everyone).
Does insurance cover Zepbound?: Most commercial insurance plans cover Zepbound with prior authorization for adults with BMI ≥30 (or ≥27 + a weight-related comorbidity). Medicare Part D excludes anti-obesity drugs by federal law, so Medicare patients pay cash unless they qualify for Lilly Cares.
Is Ozempic the same as Wegovy?: Same active molecule (semaglutide), different FDA indications and maximum doses. Ozempic = type 2 diabetes, max 2 mg/week. Wegovy = chronic weight management, max 2.4 mg/week. Insurance pathways are very different.
Can I still get compounded GLP-1 in 2026?: For semaglutide: no — FDA declared the shortage resolved February 21, 2025 and 503A compounding is no longer broadly permitted. For tirzepatide: shortage resolved October 2024 (re-affirmed December 2024), with a wind-down enforcement window that ended in 2025. Some clinics still market "compounded" formulations with added ingredients (B12, glycine) as personalized prescriptions; the legal status is contested.
How does Wegovy compare to Saxenda?: Both are GLP-1 agonists from Novo Nordisk. Wegovy (semaglutide, weekly) produces ~15% mean weight loss; Saxenda (liraglutide, daily) produces ~6-8%. Wegovy is also cheaper per kg-lost, more convenient, and has cardiovascular outcome data (SELECT trial). Saxenda was first approved for adolescents (2020); Wegovy followed in 2022 — both are available for ages 12-17.

Was this page helpful?

No user reviews yet

Be the first to share your experience — consults, shipping, billing, support. The form below takes ~2 minutes.